Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGcp Asset Bckd Regulatory News (GABI)

Share Price Information for Gcp Asset Bckd (GABI)

Share Price is delayed by 15 minutes
Get Live Data
64.00    0.00 (0.00%)
Bid:
63.60
Ask:
68.60
Spread: 5.00 (7.862%)
Market Cap: £110.02m
GABI Live PriceLast checked at - London Stock Exchange

Intraday Gcp Asset Bckd Share Chart

Additional Listing

16 Nov 2017 12:20

RNS Number : 7341W
GCP Asset Backed Income Fund Ltd
16 November 2017
 

GCP Asset Backed Income Fund Limited

(the "Company" or "GCP Asset Backed")

LEI: 213800FBBZCQMP73A815.Additional Listing

GCP Asset Backed, which invests in asset backed loans, has made an application for 120,619 ordinary shares of no par value each in the Company to be admitted to the premium segment of the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange. It is expected that these new ordinary shares will be admitted to trading on 24 November 2017.

The application is being made pursuant to the scrip dividend alternative in lieu of cash for the interim dividend for the period from 1 July 2017 to 30 September 2017 (the "Q3 Dividend"). Elections for a scrip dividend were received in respect of 3.43% of the ordinary shares in issue as at the record date of 27 October 2017. When issued, these new ordinary shares will rank pari passu with the existing ordinary shares.

Further details of the scrip dividend alternative can be found in the Scrip Dividend Circular 2017 which was published by the Company on 28 July 2017, a copy of which is available for inspection at www.morningstar.co.uk/uk/NSM and on the Company's website at https://www.graviscapital.com/funds/gcp-asset-backed.

Following admission of the new ordinary shares, the Company's issued share capital will consist of 242,966,606 ordinary shares of no par value each and 75,000,000 C shares in issue. With effect from 24 November 2017, the total number of issued shares with voting rights will be 317,966,606.

The above figure of 317,966,606 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or of a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information, please contact:

Gravis Capital Management Limited +44 (0) 20 3405 8500

David Conlon david.conlon@graviscapital.com 

Philip Kent philip.kent@graviscapital.com 

Dion Di Miceli dion.dimiceli@graviscapital.com 

Cenkos Securities plc +44 (0)20 7397 8900

Tom Scrivens tscrivens@cenkos.com 

Oliver Packard opackard@cenkos.com 

Sapna Shah sshah@cenkos.com 

 

Buchanan +44 (0)20 7466 5000

Charles Ryland charlesr@buchanan.uk.com 

Victoria Hayns victoriah@buchanan.uk.com 

 

Notes to Editors 

The Company

GCP Asset Backed is a closed ended investment company traded on the Main Market of the London Stock Exchange. Its investment objective is to generate attractive risk-adjusted returns primarily through regular, growing distributions and modest capital appreciation over the long term.

The Company seeks to meet its investment objective by making investments in a diversified portfolio of predominantly UK based asset backed loans which have contracted, predictable medium to long term cash flows and/or physical assets.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ALSGGGMGGUPMGPQ
Date   Source Headline
9th Aug 20187:00 amRNSScrip Share Reference Price
1st Aug 20187:00 amRNSInvestor Report as at 30 June 2018
26th Jul 20187:00 amRNSSpecial dividend declaration
26th Jul 20187:00 amRNSDividend Declaration & Scrip Dividend Alternative
26th Jul 20187:00 amRNSProposed C Share issue
16th Jul 20187:00 amRNSNet Asset Value(s)
29th Jun 20187:00 amRNSTotal Voting Rights
14th Jun 20185:21 pmRNSHolding(s) in Company
7th Jun 20187:00 amRNSResult of AGM
5th Jun 20189:15 amRNSAdditional Listing
24th May 20187:00 amRNSAdditional Listing
11th May 20187:00 amRNSScrip Reference Price
4th May 201811:15 amRNSNotice of AGM
30th Apr 20187:00 amRNSTotal Voting Rights
27th Apr 20187:00 amRNSInvestor Report as at March 2018
26th Apr 20187:00 amRNSDividend Declaration & Scrip Dividend Alternative
26th Apr 20187:00 amRNSAnnual Report & Financial Statements
26th Apr 20187:00 amRNSAnnual Scrip Dividend Circular 2018
17th Apr 20181:31 pmRNSTotal Voting Rights & Additional Listing
16th Apr 20187:25 amRNSConversion of C shares
11th Apr 20187:00 amRNSNet Asset Value(s)
12th Mar 20187:00 amRNSConversion of C Shares
28th Feb 20187:00 amRNSTotal Voting Rights
23rd Feb 20188:15 amRNSTotal Voting Rights & Additional Listing
16th Feb 20187:00 amRNSAdditional Listing
1st Feb 20187:00 amRNSScrip Share Reference Price
30th Jan 201810:32 amRNSInvestor Report as at 31 December 2017
17th Jan 20183:26 pmRNSDividend Declaration & Scrip Dividend Alternative
17th Jan 20187:00 amRNSNet Asset Value(s)
20th Dec 201710:11 amRNSReplacement: Holding(s) in Company
19th Dec 20177:00 amRNSMarkets in Financial Instruments Directive
30th Nov 201712:50 pmRNSTotal Voting Rights
30th Nov 20177:00 amRNSC Share Portfolio Update
16th Nov 201712:20 pmRNSAdditional Listing
2nd Nov 20177:00 amRNSScrip Share Reference Price
1st Nov 20177:00 amRNSInvestor Report as at 30 September 2017
19th Oct 20177:00 amRNSDividend Declaration & Scrip Dividend Alternative
18th Oct 20177:00 amRNSNet Asset Value(s)
16th Oct 201712:51 pmRNSHolding(s) in Company
12th Oct 20177:00 amRNSResult of OO, Placing and OFS
29th Sep 20172:51 pmRNSTotal Voting Rights
25th Sep 201711:40 amRNSC Share Issue and publication of prospectus
22nd Sep 20177:00 amRNSInterim Report and Financial Statements
4th Sep 20171:37 pmRNSAdditional Listing
4th Sep 20177:00 amRNSNew Website
31st Aug 201712:16 pmRNSTotal Voting Rights
22nd Aug 201710:50 amRNSTotal Voting Rights & Additional Listing
22nd Aug 20179:54 amRNSProposed C Share Issue
14th Aug 20177:00 amRNSNew social infrastructure investment
10th Aug 20177:00 amRNSScrip Share Reference Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.